• Patient-Derived Gastric Cancer Assembloids Enhance Drug Mode

  2026-04-30

  This study introduces a patient-derived gastric cancer assembloid system that integrates matched tumor organoids and autologous stromal cell subpopulations, more accurately recapitulating the native tumor microenvironment. The model reveals how stromal heterogeneity drives gene expression and modulates drug sensitivity, providing an advanced platform for studying resistance mechanisms and developing personalized therapies.

• Cefiderocol vs. Ceftolozane: In Vitro Activity Against Resis

  2026-04-30

  This study systematically compared cefiderocol and several β-lactam/β-lactamase inhibitor combinations, including ceftolozane-tazobactam, for their in vitro activity against European Pseudomonas aeruginosa and Acinetobacter spp. isolates. Its findings refine the clinical and experimental landscape for managing multidrug-resistant non-fermenters and inform assay development and antibacterial strategy selection.

• Bradykinin (BA5201): Technical Guide for Vasodilation Resear

  2026-04-29

  Bradykinin (SKU BA5201) is a validated endothelium-dependent vasodilator peptide enabling reproducible studies of vascular tone, permeability, and inflammation signaling. This guide details its optimal use in mechanistic assays and highlights protocol parameters, troubleshooting, and QC best practices. Bradykinin is unsuitable for diagnostic or clinical use; it is strictly for controlled laboratory workflows.

• Phos binding reagent (Phosbind) acrylamide: SDS-PAGE Workflo

  2026-04-29

  Phos binding reagent (Phosbind) acrylamide enables the antibody-free differentiation of phosphorylated and non-phosphorylated proteins during SDS-PAGE, streamlining protein phosphorylation analysis. It is recommended for basic to advanced workflows focused on proteins between 30–130 kDa but is not suited for targets outside this range or for long-term solution storage.

• Rosiglitazone (Brl-49653): Protocols & Troubleshooting in PP

  2026-04-28

  Rosiglitazone (Brl-49653) is a gold-standard PPARγ agonist transforming metabolic and diabetes research with robust, reproducible results. This article guides you through advanced experimental workflows, troubleshooting strategies, and practical insights based on recent functional genomics breakthroughs.

• Lamotrigine: Applied Workflows for Sodium Channel Research

  2026-04-28

  Lamotrigine (6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine) from APExBIO empowers next-gen electrophysiology and serotonin pathway assays with its high purity, validated solubility profile, and reproducible performance. This guide delivers optimized protocols, troubleshooting insights, and practical tips for tackling common workflow roadblocks in CNS and cardiac research.

• Testosterone Bounce as a Prognostic Biomarker in Degarelix T

  2026-04-27

  A recent multicenter study identifies 'testosterone bounce'—a transient rise in testosterone during degarelix acetate therapy—as a novel predictor of improved overall and cancer-specific survival in prostate cancer patients. This finding refines biomarker-driven prognosis in GnRH receptor antagonist–based hormone therapy, suggesting new avenues for patient stratification.

• Oligo (dT) 25 Beads: Technical Guidance for mRNA Isolation

  2026-04-27

  Oligo (dT) 25 Beads address the challenge of isolating high-purity eukaryotic mRNA by leveraging polyA tail hybridization and magnetic separation. This product is most relevant for workflows requiring intact, polyadenylated mRNA, such as RT-PCR and next-generation sequencing. It is not suitable for isolating non-polyadenylated RNA species or bacterial mRNA.

• CPSIT_0844 Drives IL-6/IL-8 via TLR2/4 and NF-κB: Mechanisms

  2026-04-26

  This study identifies the Chlamydia psittaci inclusion membrane protein CPSIT_0844 as a potent inducer of pro-inflammatory cytokines IL-6 and IL-8 in human monocytes via TLR2/TLR4-MyD88-dependent activation of JNK, p38, and NF-κB pathways. The results clarify a key bacterial mechanism underpinning severe inflammatory responses in psittacosis and suggest targeted pathways for future therapeutic intervention.

• ISRIB (trans-isomer): Precision PERK Inhibitor for ER Stress

  2026-04-25

  ISRIB (trans-isomer) from APExBIO is redefining ER stress research with its unmatched selectivity for the integrated stress response. Explore advanced workflows, application strategies, and troubleshooting tips to maximize reproducibility in apoptosis, fibrosis, and neurodegenerative disease models.

• DAPI (hydrochloride): Technical Guidance for DNA Visualizati

  2026-04-24

  DAPI (hydrochloride) provides reliable, high-contrast staining of double-stranded DNA for chromosome visualization, cell cycle analysis, and histochemical workflows. Its specificity for A-T rich DNA regions and compatibility with both fixed and live cells make it a versatile choice for cell biology research. However, its limited permeability in live cells and requirement for proper handling restrict its use in certain applications.

• Nonivamide (Capsaicin Analog): Applied TRPV1 Agonist Workflo

  2026-04-24

  Nonivamide, a potent capsaicin analog and TRPV1 agonist, brings precision to cancer research and neuroimmune assays by enabling robust apoptosis induction and tumor xenograft growth reduction. This article delivers actionable protocols, optimization strategies, and troubleshooting insights for elevating experimental reliability with Nonivamide from APExBIO.

• BV6: Selective IAP Antagonist for Apoptosis in Cancer Models

  2026-04-23

  BV6 is a potent, selective IAP antagonist that induces apoptosis in cancer cells and enhances their sensitivity to chemotherapy and radiotherapy. It demonstrates robust activity in both in vitro and in vivo models, with characterized solubility and handling parameters for reproducible research workflows.

• LARP1-TOP mRNA Complexes: Structural Insights and Functional

  2026-04-23

  This study reveals that LARP1 directly binds non-translating ribosomal subunits and associates with terminal oligopyrimidine (TOP) motif mRNAs in repressed complexes. Structural and biochemical data challenge prevailing models, showing ribosome binding is dispensable for LARP1-mediated TOP repression and stabilization, refining our molecular understanding of translational control.

• Genetic Tools for Enhanced A40926 Production in Nonomuraea

  2026-04-22

  This study introduces new molecular tools to improve the biosynthesis of A40926, a glycopeptide antibiotic and dalbavancin precursor, in Nonomuraea gerenzanensis. By optimizing promoter systems and overexpressing key regulatory genes, the researchers achieved significant increases in A40926 yield, providing a foundation for more efficient antibiotic development against resistant Gram-positive pathogens.

455 records 20/31 page Previous Next First page 上5页 1617181920 下5页 Last page